Lowenthal Richard E 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Lowenthal Richard E
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Award
Stock option (right to buy)
2025-01-02+767,600→ 767,600 totalExercise: $10.71Exp: 2035-01-01→ Common Stock (767,600 underlying) - Award
Stock Option (right to buy)
2025-01-02+261,900→ 261,900 total(indirect: By Spouse)Exercise: $10.71Exp: 2035-01-01→ Common Stock (261,900 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025.